Subsequent gene chip screening and experimental analysis indicated that the downregulation of RCAN1-4 could enhance the growth and metastasis of thyroid cancer cells by upregulating NFE2L3 expression (Wang et al., 2017). The gene discussed is NFE2L3; the disease is thyroid gland carcinoma.